ZTS insider trading

NYSE Healthcare

Zoetis Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
1,247
Last 90 days
117
Buys / sells
1% / 17%
Market cap
$56.44B

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Company website: www.zoetis.com

ZTS insider activity at a glance

FilingIQ has scored 1,247 insider transactions for ZTS since Nov 6, 2013. The most recent filing in our index is dated May 13, 2026.

Across the full history, 9 open-market purchases and 210 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ZTS insider trades is 66.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ZTS Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading ZTS

13F funds holding ZTS

Politicians who have traded ZTS

Frequently asked

How many insider trades does FilingIQ track for ZTS?
FilingIQ tracks 1,247 Form 4 insider transactions for ZTS (Zoetis Inc.), covering filings from Nov 6, 2013 onwards. 117 of those were filed in the last 90 days.
Are ZTS insiders net buyers or net sellers?
Across the full Form 4 history for ZTS, 9 transactions (1%) were open-market purchases and 210 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ZTS insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ZTS in?
Zoetis Inc. (ZTS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $56.44B.

Methodology & sources

Every ZTS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.